Mechanisms of Exertional Dyspnea in Fibrotic Interstitial Lung Disease
Condition(s):Lung; Disease, Interstitial, With FibrosisLast Updated:October 12, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Lung; Disease, Interstitial, With FibrosisLast Updated:October 12, 2016Completed
Condition(s):COPDLast Updated:June 7, 2019Completed
Condition(s):Covid19; DyspneaLast Updated:January 11, 2024Active, not recruiting
Condition(s):Heart Failure With Preserved Ejection Fraction; Chronic Pulmonary Thromboembolism (Disorder)Last Updated:August 8, 2022Recruiting
Condition(s):Pulmonary Arterial HypertensionLast Updated:January 29, 2020Withdrawn
Condition(s):Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid NeoplasmLast Updated:December 12, 2023Recruiting
Condition(s):Post-Acute COVID19 Syndrome; Long COVID; Post COVID-19 ConditionLast Updated:February 13, 2023Recruiting
Condition(s):COPDLast Updated:August 15, 2017Completed
Condition(s):COVID-19Last Updated:August 31, 2023Recruiting
Condition(s):Moderate Chronic Obstructive Pulmonary Disease; Severe Chronic Obstructive Pulmonary Disease; DyspneaLast Updated:September 18, 2013Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.